Benjamin Lichtiger, M.D., Ph.D., MBA, CQM/OE (ASQ)
Department of Physicians Network, Pathology and Laboratory Medicine
Present Title & Affiliation
Primary Appointment
Clinical Professor, Department of Laboratory Medicine, Division of Pathology/Lab Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
Education & Training
Degree-Granting Education
| 1998 | Lady of the Lake University, Houston, TX, USA, MBA |
| 1974 | The University of Texas Graduate School of Biomedical Sciences, Houston, TX, USA, PHD |
| 1964 | University of Buenos Aires, Buenos Aires, ARG, MD |
| 1958 | National College No. 1 Bernadino Rivadavia, Buenos Aires, ARG, BA |
| 1958 | National College No. 1 Bernadino Rivadavia, Buenos Aires, ARG, BS |
Postgraduate Training
| 1971-1972 | Predoctoral Fellow in Surgery, The University of Texas MD Anderson Cancer Center and Graduate School of Biomedical Sciences, Houston, TX |
| 1971-1973 | Fellow, Department of Laboratory Medicine, Division of Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX |
| 1971-1973 | Special Research Fellow, National Cancer Institutes (USPHS) Fellowship Grant, The University of Texas M. D. Anderson Cancer Center, Houston, TX |
| 1968-1971 | Fellow Department of Pathology, The University of Texas MD Anderson Cancer Center Formerly: The University of Texas System Cancer Center M. D. Anderson Hospital and Cancer Institute, Houston, TX |
| 1966-1968 | Resident Pathology, Michael Reese Hospital, Chicago, IL |
| 1965-1966 | Resident Pathology, Fernandez Hospital, Buenos Aires |
Board Certifications
| 2014 | American Board of Medical Quality |
| 2008 | American Society for Quality |
| 1975 | American Board of Pathology (Clinical Pathology) |
| 1971 | American Board of Pathology (Anatomic Pathology) |
Experience & Service
Administrative Appointments/Responsibilities
Medical Director, Department of Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 1992 - 2018
Medical Director, Department of Laboratory Medicine, The University of Texas M. D. Anderson Cancer Center, Houston, TX, 1974 - 1992
Section Chief/Transfusion Medicine, Department of Laboratory Medicine, The University of Texas M. D. Anderson Cancer Center, Houston, TX, 1974 - Present
Other Appointments/Responsibilities
Member/Board of Directors, San Jose Clinic, Houston, TX, 2004 - 2011
Member, NHLB1 Special Emphasis Panel-Transfusion Medicine/Hemostasis Clinical Research Network, Houston, TX, 2002 - Present
Chairman/Finance Investment Committee, American Association of Blood Banks, Houston, TX, 2001 - Present
Member/Technical Advisory Committee, Gulf Coast Regional Blood Center, Houston, TX, 1976 - Present
Institutional Committee Activities
Member, Faculty Focus Group, 2000 - Present
Selected Publications
Peer-Reviewed Articles
- Aung FM, Lichtiger B, Rondon G, Yin CC, Alousi A, Ahmed S, Andersson BS, Bashir Q, Ciurea SO, Hosing C, Jones R, Kebriaei P, Khouri I, Nieto Y, Oran B, Parmar S, Qazilbash M, Shah N, Shpall EJ, Champlin RE, Popat U. Pure Red Cell Aplasia in Major ABO Mismatched Allogeneic Hematopoietic Stem Cell Transplantation Is Associated with Severe Pancytopenia. Biol Blood Marrow Transplant 22(5):961-5, 2016. e-Pub 2016. PMID: 26921820.
- Ciurea SO, Thall PF, Milton DR, Barnes TH, Kongtim P, Carmazzi Y, Lopez AA, Yap DY, Popat U, Rondon G, Lichtiger B, Aung F, Afshar-Kharghan V, Ma Q, Fernandez-Vina M, Champlin RE, Cao K. Complement-Binding Donor-Specific Anti-HLA Antibodies and Risk of Primary Graft Failure in Hematopoietic Stem Cell Transplantation. Biol Blood Marrow Transplant 21(8):1392-8, 2015. e-Pub 2015.
- Aung F, Lichtiger B, Bassett R Jr, Hosing C, Freireich E. Granulocyte Concentrates from a Single High-yield Apheresis Can Be Split to Support Multiple Patients. Leukemia and Lymphoma 55(11):2577-83, 2014. e-Pub 2014. PMID: 24456072.
- Ricci KS, Martinez F, Lichtiger B, Han XY. Septic transfusion reactions during blood transfusion via indwelling central venous catheters. Transfusion 54(10):2412-8, 2014.
- Aung F, DiNardo CD, Martinez F, Pierce S, Daver N, Kadia T, Jabbour E, Kantarjian H, Lichtiger B, Freireich EJ. A Phase II Study of Prophylactic Non-irradiated Granulocyte Transfusions in AML Patients Receiving Induction Chemotherapy. Blood Disorders and Transfusion.
- Arora K, Kelley J, Dawen S, Jing N, Martinez F, Lichtiger B, Tholpady A. Cancer Type Predicts Alloimmunization Following RhD Incompatible RBC Transfusions. Transfusion.
- Salam A, Hosain M, Lichtiger B. Immediate Adverse Reactions to Platelet Transfusions: Whole Blood-Derived versus Apheresis Platelets. Transfusion.
- Hashmi G, Patel D, Zhang Y, Seul M, Aung F, Cano P, Freireich E, Lichtiger B. Preventing Platelet Alloimmunization for Patients with Hematologic Malignancies: Rapid HLA-class I and HPA Immunogenetic Profiling to Enable Selection of Optimally Matched Platelets.
Abstracts
- Hashmi G, Patel D, Seul M, Aung F, Lichtiger B. Toward Optimal Selection of Cellular Products for Hematology/Oncology Patients Eliminating Adverse Effects. Clinical Lymphoma, Myeloma & Leukemia 14(Supplement 3):S158, 2014.
- DiNardo CD, Aung FM, Martinez F, Daver N, Kadia TK, Jain N, Jabbour E, Reddy V, Garcia-Manero G, Cortes JE, Ravandi F, Kantarjian HK, Lichtiger B, Freireich EJ. A Phase II Feasibility Study of Prophylactic White Cell Transfusions for the Prevention of Infection in AML Patients Undergoing Induction Chemotherapy. Blood 124(21):1564, 2014.
- Aung FM, Bassett RI, Lichtiger B, Freireich EJ, Khouri I. Overall Survival in Hematopoietic Stem Cell Transplantation Is Not Correlated with Age of Red Cells Transfused Pre- and Post-transplantation. Blood 124(21):1213, 2014.
- Arora K, Martinez F, Lichtiger B. ABO Incompatible Granulocyte Transfusions: Experience at a Large Hospital Based Blood Center. Clinical Apheresis 29, 2014.
- Martinez F, Lichtiger B. Platelet refractoriness and use of vincristine-laden platelets in patients with hematologic malignancies. Transfusion 54(21), 2014.
- Aung FM, Lichtiger B, Popat UR, Champlin RE, Ciurea SO. Donor Leucocyte Buffy Coat Infusion to Patients with Donor Specific HLA Antibodies Undergoing Haploidentical Hematopoietic Stem Cell Transplantation.
- Aung FM, Lichtiger B, Rondon G, Yin CC, Alousi A, Ahmed S, Andersson B, Bashir Q, Ciurea S, Hosing C, Jones R, Kebriaei P, Khouri I, Nieto Y, Betul O, Parmar S, Qazilbash M, Shah N, Sphall E, Champlin R, Popat U. Pure Red Cell Aplasia in Major ABO Mismatched Allogeneic Hematopoietic Stem Cell Transplantation Is Associated with Severe Pancytopenia. Human Immunology.